Reports, Whitepapers & Articles

Combining digital technology and human connection in patient engagement is crucial to meet the evolving needs of patients. With more empowerment coming from patients, we must strive to cater directly to their needs.

The landscape of healthcare continues to change. Patient engagement is a crucial factor in attaining better outcomes and delivering personalized care. How does a company build authentic relationships with patients?

In pharma especially, natural language processing is playing a crucial role in capturing insights from diverse sources.

AI chatbots: with nearly 80% of companies having implemented or planning to implement chatbots soon, the patient support delivery model is rapidly changing.

VMS whitepaper – To truly make a difference in patients’ lives, pharmaceutical companies must shift their focus to providing individualized, holistic support that considers each patient’s unique circumstances and needs.

How brands are putting in place initiatives to increase awareness and access to patient support programs, with the goal of reaching as many patients as possible.

Several VMS team members attended Asembia’s 2023 Specialty Pharmacy Summit. Here are our key takeaways.

A digitally integrated, human-centric approach to patient support is being adopted as the standard for best-in-class patient services programs.

How biopharma companies can address the gaps in the care model and have a positive impact on health inequities in the US.

Our March Patient Services Report explores how certain market forces are enabling companies to move from a one-size-fits-all patient support model to a 1:1 patient support model.

What are the root causes of health inequity in the US and how the biopharma industry is responding.

This report focuses on the digitally integrated, human-centered approach to patient engagement and how this model is enabling biopharma to deliver an elevated patient experience.

As an industry, we need to continually be evaluating the patient voice to better design and implement digital health tools to give patients what they need and want.

A new generation of patient engagement services like MY Journey™ are being utilized to create an integrated environment where human engagement, technology and data co-exist in harmony.

One Voice is a high-touch, data driven, technology-enabled patient support platform that connects patients to an experienced and trained Clinical Nurse Educator as a single point of contact during the entire treatment journey.

As the market for digital health applications grows, patients are rapidly embracing a variety of tools to take control of their health and manage their disease.

To deliver a superior patient experience and address the evolving expectations of patients, biopharma is rapidly integrating digital health tools into patient engagement.

Home health services are increasingly seen as a way to alleviate prescription abandonment and improve medication adherence.

Utilizing behavioral science to guide support interventions is critical to achieve the maximum efficacy and efficiency of patient engagement programs.

As the biopharma industry intensifies its approach to patient engagement, these proven results are becoming critical success factors.

A new generation of patient engagement programs is creating an integrated environment where human engagement, technology and data co-exist in symbiosis.

Many companies are now shifting focus to how AI can be leveraged in the commercial stage, specifically in patient engagement given its profound potential to impact the last mile of care delivery.

Review key findings and takeaways from a national survey of HCPs to better understand the opportunities HCPs believe exist for enhancing the support provided by life science companies to both their medical practices and their patients.

As biopharma shifts its outlook to the post-COVID era, there is an opportunity for the industry to transform how it delivers patient and HCP engagement.

This issue explores how patients have responded to the digital transformation and why 86% of tech professionals said the pharma digital moment has arrived.

In our July Patient Services Report, we provide an in-depth look at the recent rare disease market and evaluate the investment biopharma is making to enhance patient and HCP support in this space.

Certain pandemic driven trends will continue to persist, thus having lasting impacts on how we develop commercial strategies.

Patient barriers and HCP challenges result in 84% of patients making errors in self-injecting and 45% of patients skipping and avoiding their injections altogether.

In our April Patient Services Report, we explain how to measure patient support programs to assess their impact on patient adherence.

In the March Patient Services Report, we share insights on how clients are navigating this and recent technology and model innovations that have enabled success.

Patient adherence has become a competitive driver for the life sciences industry to realize the full clinical potential of their therapies and achieve even greater commercial success.

In our February Patient Services Report, VMS explores why patient adherence has become a competitive driver and is no longer optional for biopharma to invest in.

Here’s what we believe are the most notable trends for 2021 and a few of our takeaways from the CEC and JP Morgan Healthcare conference this month

VMS Clinical Nurse Educators explain in this PM360 article how biopharma companies can support patient caregivers

VMS continually conducts primary and secondary research to identify the latest trends in the behavioral health space

Biopharma is addressing patient adherence during COVID-19, by leveraging predictive analytics and tech-enabled support models like OneVoiceTM

Read VMS CEO Andrea Heslin Smiley’s comments in this MM&M e-book

Industry also can play a role in supporting patient transitions to ensure the safe use of prescribed products and therapy management

Read VMS SVP Abigail Mallon’s comments in this PharmaVOICE article

Results of a healthcare professional survey we conducted on behalf of our biopharma clients

An interview with VMS CEO Andrea Heslin Smiley in the American Nurses Foundation newsletter

Read VMS SVP Abigail Mallon’s comments in this PharmaVOICE article

PharmaVOICE article illustrates why VMS clinical educators are driven to help patients on a 1:1 basis to manage chronic illnesses

Across our Biopharma programs, numerous patient and HCP insights demonstrate the large and growing impact CNEs are having

Read VMS SVP Abigail Mallon’s comments in PM360 magazine

PM360 magazine selected the VMS Insight Incubator™ as one of the most innovative services in the biopharma industry in 2019

The pandemic remains a highly prevalent factor requiring biopharma to deploy innovative HCP and patient engagement for the new normal

Biopharma R&D innovation and the role of Clinical Nurse Educators

Market forces and pandemic-related trends are increasing biopharma’s need to focus on areas where Clinical Nurse Educators can drive impact

Risk of patient non-adherence is at an all-time high

Patients receiving health coaching were almost 4X as likely to be adherent to medications

VMS shares recent insights from our Clinical Educators

Patient adherence is at the forefront of the conversation and is becoming a top business priority for Biopharma this year.